Nur-Sultan All COVID-19-related restrictions have been eliminated as the epidemic has stabilised. Kazakhstan’s Health Minister Azhar Giniyat reported on May 18 that 98% of COVID-19 patients have recovered.
Since the breakout of COVID-19 in 2020, there have been 1,305,667 coronavirus cases in the country.
Since the pandemic began, the government has spent nearly $2 billion. This year, 86 billion tenge ($199 million) has been set aside for VeroCell and QazVaq vaccine acquisitions and Pfizer.
Giniyat says 11,000 people are immunised daily. As of May 18, 9.4 million patients had received one dosage and 9.2 million had finished the regimen. Four million were re-immunized.
As of May 19, 1.1 million people had received a single Pfizer vaccination shot, with 996,207 obtaining the full dose. Pfizer’s current stockpile is 1 million doses, but 500,000 will last until June.
Kazakhstan ranked 55th out of 195 countries in the John Hopkins Department of Health Security, the Nuclear Threat Initiative, and the Economist Intelligence Unit’s Global Health Security (GHS) Index (EIU).